Point72 Asset Management’s Merck MRK Stock Holding History

Point72 Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.02M	Buy	70,200 +1,500	+2%	+$176K	0.01%	1347
2026 Q1	$8.26M	Buy	68,700 +6,900	+11%	+$797K	0.01%	1374
2025 Q4	$6.51M	Buy	61,800 +14,400	+30%	+$1.35M	0.01%	1642
2025 Q3	$3.98M	Buy	47,400 +39,300	+485%	+$3.24M	0.01%	1158
2025 Q2	$641K	Sell	8,100 -93,900	-92%	-$7.46M	﹤0.01%	1711
2025 Q1	$9.16M	Buy	102,000 +100,000	+5,000%	+$9.34M	0.02%	713
2024 Q4	$199K	Sell	2,000 -100,000	-98%	-$10.3M	﹤0.01%	1888
2024 Q3	$11.6M	Buy	102,000 +100,000	+5,000%	+$11.9M	0.03%	597
2024 Q2	$248K	Hold	2,000	–	–	﹤0.01%	1578
2024 Q1	$264K	Hold	2,000	–	–	﹤0.01%	1825
2023 Q4	$218K	Sell	2,000 -37,500	-95%	-$3.89M	﹤0.01%	1783
2023 Q3	$4.07M	Buy	+39,500	New	+$4.26M	0.01%	944
2023 Q1	–	Sell	-55,000	Closed	-$6.1M	–	2429
2022 Q4	$6.1M	Buy	+55,000	New	+$5.62M	0.02%	703

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Point72 Asset Management's MRK Position: Q2 2026 in Review

Point72 Asset Management reduced its Merck (MRK) stake by 59% in Q2 2026, selling an estimated $63.3M and leaving 380,081 shares worth $48.8M. The position accounts for 0.05% of the portfolio, ranked #440.

Point72 Asset Management first reported a position in MRK in Q2 2014 and has held it in 31 quarters since. The position peaked at $294M in Q1 2022. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Point72 Asset Management held 380,081 shares of Merck worth $48.8M as of Q2 2026.
Point72 Asset Management sold 540,996 Merck shares in Q2 2026, an estimated $63.3M.
Merck made up 0.05% of Point72 Asset Management's portfolio in Q2 2026, its #440 holding.
Point72 Asset Management first reported a position in Merck in Q2 2014 and has held it in 31 quarters since.
Point72 Asset Management's Merck position peaked at $294M in Q1 2022.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.